会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 7. 发明申请
    • Hypoxia-regulated genes
    • 低氧调控基因
    • US20090036662A1
    • 2009-02-05
    • US12157821
    • 2008-06-13
    • Paz EinatRami SkaliterSylvie Luria
    • Paz EinatRami SkaliterSylvie Luria
    • C07H21/02
    • C07K14/47A61K38/00A61K48/00C07K14/4702C07K14/4747
    • According to the present invention, purified, isolated and cloned nucleic acid polynucleotide encoding hypoxia-regulating genes and the proteins thereof and antibodies directed against the proteins which have sequences as set forth in SEQ ID No:1, SEQ ID No:2, SEQ ID No:3, SEQ ID No:4, SEQ ID No:5 and SEQ ID No:6 are provided. The present invention further provides transgenic animals and cell lines as well as knock-out organisms of these sequences. The present invention further provides methods of regulating angiogenesis or apoptosis or regulating response to hypoxic conditions in a patient in need of such treatment. The present invention also provides a method of diagnosing the presence of ischemia in a patient including the steps of analyzing a bodily fluid or tissue sample from the patient for the presence or gene product of at least one expressed gene (up-regulated) as set forth in the group comprising SEQ ID No:2; SEQ ID No:3; SEQ ID No:4; SEQ ID No:5; and SEQ ID No:6 and where ischemia is determined if the up-regulated gene or gene product is ascertained.
    • 根据本发明,编码缺氧调节基因及其蛋白质的纯化,分离和克隆的核酸多核苷酸和针对具有SEQ ID No:1,SEQ ID No:2,SEQ ID NO:2所示序列的蛋白质的抗体 提供了No.3,SEQ ID No:4,SEQ ID No:5和SEQ ID No:6。 本发明进一步提供这些序列的转基因动物和细胞系以及敲除生物体。 本发明还提供了在需要这种治疗的患者中调节血管发生或凋亡或调节对缺氧条件的反应的方法。 本发明还提供了一种诊断患者局部缺血的方法,包括以下步骤:从患者体内分析至少一种表达基因(上调)的存在或基因产物,如上所述 在包含SEQ ID No:2的组中; SEQ ID No:3; SEQ ID No:4; SEQ ID No:5; 和SEQ ID No:6,如果确定上调基因或基因产物,则确定缺血。
    • 9. 发明授权
    • Hypoxia-regulated genes
    • 低氧调控基因
    • US07973156B2
    • 2011-07-05
    • US12157821
    • 2008-06-13
    • Paz EinatRami SkaliterSylvie Luria
    • Paz EinatRami SkaliterSylvie Luria
    • C07H21/04A61K48/00C12Q1/68
    • C07K14/47A61K38/00A61K48/00C07K14/4702C07K14/4747
    • According to the present invention, purified, isolated and cloned nucleic acid polynucleotide encoding hypoxia-regulating genes and the proteins thereof and antibodies directed against the proteins which have sequences as set forth in SEQ ID No:1, SEQ ID No:2, SEQ ID No:3, SEQ ID No:4, SEQ ID No:5 and SEQ ID No:6 are provided. The present invention further provides transgenic animals and cell lines as well as knock-out organisms of these sequences. The present invention further provides methods of regulating angiogenesis or apoptosis or regulating response to hypoxic conditions in a patient in need of such treatment. The present invention also provides a method of diagnosing the presence of ischemia in a patient including the steps of analyzing a bodily fluid or tissue sample from the patient for the presence or gene product of at least one expressed gene (up-regulated) as set forth in the group comprising SEQ ID No:2; SEQ ID No:3; SEQ ID No:4; SEQ ID No:5; and SEQ ID No:6 and where ischemia is determined if the up-regulated gene or gene product is ascertained.
    • 根据本发明,编码缺氧调节基因及其蛋白质的纯化,分离和克隆的核酸多核苷酸和针对具有SEQ ID No:1,SEQ ID No:2,SEQ ID NO:2所示序列的蛋白质的抗体 提供了No.3,SEQ ID No:4,SEQ ID No:5和SEQ ID No:6。 本发明进一步提供这些序列的转基因动物和细胞系以及敲除生物体。 本发明还提供了在需要这种治疗的患者中调节血管发生或凋亡或调节对缺氧条件的反应的方法。 本发明还提供了一种诊断患者局部缺血的方法,包括以下步骤:从患者体内分析至少一种表达基因(上调)的存在或基因产物,如上所述 在包含SEQ ID No:2的组中; SEQ ID No:3; SEQ ID No:4; SEQ ID No:5; 和SEQ ID No:6,如果确定上调基因或基因产物,则确定缺血。